MedTrace Logo

Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia"

NCT05157503 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2021-12-15

No results posted yet for this study

Summary

In connection with the transition to the 8th version of the classification of lung cancer according to the TNM system, there are currently no precise epidemiological data on stage III NSCLC, clinical characteristics of patients in this group, approaches to therapy and treatment results in the Russian Federation. The published statistics only provide information on the overall incidence of stage III lung, trachea and bronchial cancer, which is about 40%. This observational study will make it possible to characterize the Russian population of stage III non-small cell lung cancer patients, approaches to choosing a treatment option for stage III NSCLC and the outcomes of this treatment in real clinical practice.

Conditions

  • Stage III Non-small Cell Lung Cancer

Sponsors & Collaborators

  • Autonomous Non-Profit Organization National Society of Onco-Pulmonologists

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-10
Primary Completion
2023-01-15
Completion
2023-03-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05157503 on ClinicalTrials.gov